Velasof (Sofosbuvir/Velpatasvir) 400 mg / 100 mg
Velasof is a pan-genotypic fixed-dose combination aimed at curing Hepatitis C. Active ingredients: Sofosbuvir (400 mg) + Velpatasvir (100 mg).
Manufacturer: Hetero Healthcare (India). Generic equivalent of the blockbuster drug Epclusa.
The Universal Cure:
Velasof is designed to treat ALL genotypes (1 through 6) of the Hepatitis C virus. It simplifies treatment as it eliminates the absolute need for genotyping testing in resource-limited settings. It is particularly superior for treating the difficult Genotype 3.
✅ High Cure Rate: Achieves SVR12 (cure) in >95-99% of patients.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 25.02.2026
What Customers Say
No reviews yet
Your review can be the first!